Pages that link to "Q112670"
Jump to navigation
Jump to search
The following pages link to mastocytosis (Q112670):
Displaying 50 items.
- Theodore Maiman (Q315399) (← links)
- cromoglicic acid (Q416427) (← links)
- Hubertus Czernin (Q1465360) (← links)
- systemic mastocytosis (Q3851644) (← links)
- cutaneous mastocytosis (Q3851645) (← links)
- Category:Deaths from mastocytosis (Q8366342) (← links)
- (Q12121796) (redirect page) (← links)
- spleen mast cell malignancy (Q19000412) (← links)
- Mastocytosis: a mutated KIT receptor induced myeloproliferative disorder (Q36210845) (← links)
- Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options (Q37854888) (← links)
- Mastocytosis: from a Molecular Point of View (Q39446801) (← links)
- Effect of Dietary Fiber and Metabolites on Mast Cell Activation and Mast Cell-Associated Diseases. (Q55079819) (← links)
- Study of Mast Cell Precursors (Q61694847) (← links)
- Ontak (Denileukin Diftitox) in Patients With Systemic Mastocytosis (SM) (Q61917830) (← links)
- Everolimus (RAD001) as Therapy for Patients With Systemic Mastocytosis (Q61921137) (← links)
- A Study of Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Blood Related Cancers (Q62105336) (← links)
- Use of Tamoxifen in Systemic Mastocytosis (Q63336313) (← links)
- Imatinib in KIT-negative Systemic Mastocytosis (Q63338838) (← links)
- Clonal Mast Cell Disorders in Exercise-Induced Anaphylaxis (Q63338892) (← links)
- Adaptation of the Questionnaire "Regarding Patient's Quality of Life With Mastocytosis" in the French Language (Q63394628) (← links)
- Mast Cell Activation Test in Allergic Disease (Q63404433) (← links)
- (PATHFINDER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, in Patients With Advanced Systemic Mastocytosis (Q63571694) (← links)
- (PIONEER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, Versus Placebo in Patients With Indolent and Smoldering Systemic Mastocytosis (Q63587771) (← links)
- Cause and Natural Course of Pediatric-Onset Mastocytosis (Q63804984) (← links)
- Safety and Efficacy of Subcutaneous Sarilumab in Improving the Quality of Life in People With Indolent Systemic Mastocytosis (Q63811607) (← links)
- Masitinib in Patients With Mastocytosis With Handicap and Bearing the D816V Mutation (Q63816621) (← links)
- Cladribine Plus Pegylated Interpheron Alfa-2a in Systemic Mastocytosis (Q63843725) (← links)
- (EXPLORER) Study of BLU-285 in Patients With Advanced Systemic Mastocytosis (AdvSM) and Relapsed or Refractory Myeloid Malignancies (Q64139557) (← links)
- Study of Factors Regulating Mast Cell Proliferation (Q64171042) (← links)
- Interest of Denosumab Treatment in Osteoporosis Associated to Systemic Mastocytosis (Q64172060) (← links)
- Cutaneous Mastocytosis in Children: Analysis of Somatic and Germline Mutations (Q64172271) (← links)
- Dasatinib as Therapy for Myeloproliferative Disorders (MPDs) (Q64188812) (← links)
- Pregnancy and Medically Assisted Conception in Rare Diseases (Q64375254) (← links)
- Ibrutinib in Treating Patients With Advanced Systemic Mastocytosis (Q64396053) (← links)
- Diagnostic Value of Bone Marrow Tryptase in Systemic Mastocytosis (Q64396721) (← links)
- SL-401 in Advanced, High Risk Myeloproliferative Neoplasms (Systemic Mastocytosis, Advanced Symptomatic Primary Eosinophilic Disorder, Myelofibrosis, Chronic Myelomonocytic Leukemia) (Q64600277) (← links)
- Midostaurin in Indolent Systemic Mastocytosis (Q64622418) (← links)
- Cromoglicate in Mastocytosis (Q64640349) (← links)
- Study on Mastocytosis for Rupatadine Treatment (Q64647440) (← links)
- A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies (Q64649715) (← links)
- Evaluation of Response of Dasatinib to Treat Mastocytosis (Q64662710) (← links)
- Obatoclax for Systemic Mastocytosis (Q64676991) (← links)
- Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis (Q64696981) (← links)
- Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia (Q64710650) (← links)
- Thalidomide in Treating Patients With Relapsed or Progressive Systemic Mastocytosis (Q64716013) (← links)
- Mechanisms of Action of Photo(Chemo)Therapy in Skin Diseases (Q64789561) (← links)
- A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies (Q65319344) (← links)
- The Significance of Blood-tryptase and c-Kit Mutation in Insect Venom Immunotherapy (Q65341823) (← links)
- Treatment of Indolent Systemic Mastocytosis With PA101 (Q65344874) (← links)
- The Effect of Xolair ® (Omalizumab) in Mastocytosis Patients (Q65376321) (← links)